AKAP‐4: a novel cancer testis antigen for multiple myeloma
Maurizio Chiriva‐Internati(Texas Tech University), Everardo Cobos(Texas Tech University), Raffaele Ferrari(Texas Tech University), Eldo E. Frezza(Texas Tech University), Fabio Grizzi(Humanitas University), W. Martin Kast(University of Southern California), Nicoletta Gagliano(University of Milan), Cody Hamrick(Texas Tech University), Yuefei Yu(Texas Tech University), Marjorie Jenkins(United States Food and Drug Administration), Nicholas D’Cunha(Texas Tech University), Fred Hardwick(Texas Tech University)
Cited by 46
Related Papers
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells
|Nature Medicine|2002|549